OasisLMS

The primary target audience includes Nurse Practitioners, Physician Assistants, Pharmacists.
The secondary target audience is Endocrinologists and Other Clinicians who treat endocrine conditions.

At the end of this activity, participants will be able to: 

• Identify key features of current diabetes technologies and explain their impact on patient outcomes.
• Explain how advances in diabetes technology improve physician associates’ ability to monitor and manage diabetes.
• Apply knowledge of diabetes technologies to interpret glycemic trends and support patient self-management.
• Differentiate traditional insulin pens from smart pens and smart caps.
• Describe continuous glucose monitors (CGMs), including how they work, available types, and key benefits and limitations.
• Plan and conduct effective patient visits that incorporate CGM data through clinical software integration for real-time glucose review.
• Summarize diabetes technologies that support real-time glucose monitoring and insulin-delivery decision-making.

Physician Credit

The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  

The American College of Endocrinology (ACE) designates enduring activity for a maximum of 6 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit

Provider approved by the California Board of Registered Nursing, Provider Number 17762, for 6 contact hours.

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit.  

Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared.  

The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.  

Planner Disclosures

All of the relevant financial relationships listed for these individuals have been mitigated. All other planners for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. 

Faculty Disclosures 

All of the relevant financial relationships listed for these individuals have been mitigated. All other faculty for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Reviewer Disclosures

None of the reviewers for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.